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ABSTRACT : The risk of occupational transmission of human immunodeficiency 
virus (HIV) to health care workers with intensive exposure to HIV infected patients was 
considered, because the author autopsied an acquired immunodeficiency syndrome (AIDS) 
patient in February 1990. A few case reports suggested that the risk of HIV infection 
incurred when health care workers are exposed to blood or body fluids of HIV infected 
patients through accidental needle-stick exposure or contamination of an open wound 
or mucous membrane. For the prevention of AIDS, the pathologists and staff must use 
double-gloves, gown, mask, apron, shoes cover, medical cap, undershirt, pant, and goggle 
when in contact with AIDS patient-related materials during postmortem procedure and 
treatment of surgical speciments.
      HISTORY OF AIDS 
 In June and July of 1981, the Centers for 
Disease Control (CDC) reported the cases of an 
extremely uncommon opportunistic infection of 
Pneumocystis carinii pneumonia, other oppor-
tunistic infections, and a very rare skin tumor 
of Kaposi's sarcoma. They were first report-
ed in New York and California in epidemic 
proportions among previously healthy young 
homosexual and bisexual men who were not 
previously known to be predisposed to these 
diseases"". The opportunistic infections seen 
in these patients essentially never occur in 
people with normal immune function and it is 
a fact that these patients had a severe immune 
defect. Very high incidence of Kaposi's sarcoma 
was seen in this disease. Kaposi's sarcoma is 
an unusually aggressive form of this disease and 
has been reported to occur at an increased 
frequency among patients receiving immuno-
supperssive drugs. Therefore, Kaposi's sarcoma 
in this disease also provided clinical evidence 
for a cellular immune defect. In early 1982, this 
disease entitied specific pattern of immuno-
deficiency which was named the acquired im-
munodeficiency syndrome (AIDS) by the Centers 
for Disease Control (CDC). The term "syn-
drome" has been used because AIDS does not 
constitute a single illness which has opportun-
istic infections and neoplasms associated with 
acquired disorder of cell-mediated immunity. 
When the early cases of AIDS were reported, 
many hypotheses were proposed to explain the 
possible causes of this syndrome associated 
with cell-mediated immune dysfunction. Epide-
miologic evidence strongly supported the hy-
pothesis that AIDS was due to a specific viral 
agent. The common cell-mediated immuno-
deficiency was characterized by the specific 
depletion of the T-helper lymphocytes. AIDS 
was caused by human retrovirus which was 
initially discovered and isolated from AIDS
patients in 1983 at the Institute Pasteur in Par-
is by Luc Montagnier and his associates, 
and named lymphadenopathy associated virus 
(LAV)". Several months later in 1984, retrovirus 
was cultured from AIDS patients in the United 
States of America by Robert Gallo and his 
collegues at the National Cancer Institute, and 
named human T-cell lymphotropic virus type 
III (HTLV-III)7' 13'. The virus has been renamed 
the human immunodeficiency virus (HIV) by the 
International Committee on the Taxorromy of 
Viruses in 1986. 
 Several case investigations suggested that the 
risk of HIV infection incurred when health care 
workers were exposed to blood or body fluids 
of HIV infected patients through accidental 
needle-stick exposure or contamination of an 
open wound or mucous membrane. The risk 
of occupational transmission of HIV to health 
care workers with intensive exposure to HIV 
infected patients was considered, because the
authors autopsied AIDS patient in February 
1990.
PREVENTION OF HEALTH CARE WORKERS 
 Transmission of the immunodeficiency virus 
(HIV) has been under investigation since the 
epidemic of AIDS was recognized in 1981. The 
occupational risk of infection by this kind of 
exposure is extremely low, considering the very 
few documented cases reported among the large 
number of health care workers who have been 
exposed to blood infection with HIV" 8, 16) The 
virus has been isolated from the blood'' 7, 10) 
semen"', tears", saliva`1' 11', breast mile", vaginal 
secretion" 17> and cerebrospinal fluid"', from 
HIV infected patients. Although the virus has 
been detected in very low titers in these body 
fluids, they serve as significant vehicles for the 
transmission of HIV infection. Transmission 
of HIV by sexual contact with infected individ-
Fig. 1. Front of dissector : The author wear 
       double-gloves, gown, mask, goggle, apron, 
       shoes cover, undershirs, pant, and medical 
       cap.
Fig. 2. Back of dissector : The author wear 
       double-gloves, gown, mask, goggle, apron, 
       shoes cover, undershirs, pant, and medical 
       cap.
uals, by direct inoculation of contaminated 
blood products and by perinatal exposure in 
children born to infected mother is well docu-
mented. The epidemiology of transmission of 
HIV is similar in some respects to transmission 
of hepatitis B virus which have prompted 
considerable concern regarding the possibility 
of HIV transmission to health care workers 
through occupational exposures to infected 
patients, blood, and body fluids. The risk of 
health care workers who have had frequent 
contact with HIV infected materials by direct 
skin, or mucosa exposure to HIV infected blood 
or other body fluids, or contact with open 
wounds, is high. However, the chance of 
occupational transmission of HIV is very low. 
In order to prevent potential HIV infection, it 
is essential that all health care workers observe 
the same precautions used to protect themselves 
against accidental infection with hepatitis B 
virus by using surgical gloves when handling 
all patients' blood and body fluids. Extreme care 
should be taken to avoid accidental wounds 
from sharp instruments contamined with 
potentially infectious materials or from needles 
used on AIDS patients, and to avoid contact of 
open skin lesions with materials from AIDS 
cases. During postmortem procedures, the 
pathologists and staff should follow the general 
safety consideration as well as the guidlines 
described for hepatitis B virus infected mate-
rials. Double-gloves, gown, mask, goggle, apron, 
shoes cover, medical cap, undershirt, pant, and 
hand washing are required when in contact with 
AIDS patient-related materials (Figs. 1 and 2).
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